Two of China's biggest pharmaceutical companies, Shanghai Fosun Pharmaceutical Co. Ltd. and Shanghai Pharmaceuticals Holding Co. Ltd., have confirmed bids for a stake in Atlanta-based Arbor Pharmaceuticals LLC in a deal that could be worth upwards of $2 billion, depending on the valuation. Read More
Sinovac Biotech Ltd., of Beijing, reported that Nasdaq has granted the company an exemption from a listing rule to allow it extra time to file its 2016 annual report on form 20-F while it conducts an internal investigates into complaints lodged against the company and its sales practices and policies. The market extended the deadline for complying with the rule until Oct. 30. Read More
HONG KONG – With a booming global market for attention deficit hyperactivity disorder (ADHD) drugs, Durect Corp. is on track to deliver a potentially new, profitable product. The company has achieved positive results in its phase III clinical study of the Oradur-methylphenidate extended-release (ER) capsule administered once a day. Read More
LONDON – Cellact Pharma GmbH has sealed a $250 million plus royalties deal with Mundipharma International Ltd. for its phase II anticancer prodrug, Cap7.1. Read More
HONG KONG – Lumosa Therapeutics Co. Ltd. is exploring the neurology and pain management space with a model designed for biopharmas without huge drug discovery budgets. Read More
HONG KONG – New flexible belt- and fiber-shaped electrodes in sodium ion-containing batteries (SIBs) with aqueous electrolytes, which have promising potential applications as safe power sources for wearable or implantable medical devices, have been developed by Chinese researchers. Read More
